tm
Seeing Is Believing
tm
Seeing Is Believing
KPTI is currently covered by 5 analysts with an average price target of $15.09. This is a potential upside of $32.32 (112.83%) from yesterday's end of day stock price of $7.09.
Karyopharm Therapeutics's activity chart (see below) currently has 57 price targets and 93 ratings on display. The stock rating distribution of KPTI is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 50.79% with an average time for these price targets to be met of 365.43 days.
Highest price target for KPTI is $28, Lowest price target is $6, average price target is $15.09.
Most recent stock forecast was given by from HC WAINWRIGHT on 06-May-2026. First documented stock forecast 02-Jun-2015.
Currently out of the existing stock ratings of KPTI, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Feb-2026
$13
$2.79 (27.33%)
$8
2 months 21 days ago
(06-May-2026)
1/4 (25%)
$3.98 (44.12%)
15
Buy Since 09-Oct-2025
$16
$5.79 (56.71%)
$8
3 months ago
(27-Apr-2026)
1/3 (33.33%)
$7.34 (84.76%)
10
Buy Since 03-Nov-2023
$15
$4.79 (46.91%)
$21
4 months 2 days ago
(25-Mar-2026)
3/5 (60%)
$9.79 (187.91%)
1410
Buy Since 10-Mar-2026
$28
$22.52 (410.95%)
$330
4 months 17 days ago
(10-Mar-2026)
1/2 (50%)
$19.77 (240.22%)
1085
Buy Since 06-Jan-2023
$19
$8.79 (86.09%)
8 months 23 days ago
(04-Nov-2025)
7/17 (41.18%)
$13.35 (236.28%)
312
What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?
